Cite

HARVARD Citation

    Taylor, G. et al. (2022). Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes. Diabetic medicine. 39 (5), p. n/a. [Online]. 
  
Back to record